Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.02% |
| 2 | Healthcare | 2.92% |
| 3 | Consumer Discretionary | 2.17% |
| 4 | Financials | 2.1% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4726
Coherus Oncology
CHRS
$204M
| $2.97M | ﹤0.01% |
2,857,208
+13,760
| +0.5% | +$18.9K |
|
|
PPL
4727
PUT
PPL Corp
PPL
$26.7B
| $2.97M | ﹤0.01% |
89,800
+300
| +0.3% | +$9.18K |
|
4728
LeMaitre Vascular
LMAT
$1.88B
| $2.97M | ﹤0.01% |
31,940
-42,724
| -57% | -$3.7M |
|
4729
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.38B
| $2.97M | ﹤0.01% |
86,052
-133,602
| -61% | -$4.3M |
|
4730
CALL
Mattel
MAT
$4.15B
| $2.96M | ﹤0.01% |
155,600
-18,900
| -11% | -$348K |
|
4731
State Street SPDR Portfolio Intermediate Term Treasury ETF
SPTI
$10.7B
| $2.96M | ﹤0.01% |
+101,998
| New | +$2.93M |
|
|
ITCI
4732
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.96M | ﹤0.01% |
40,500
-20,800
| -34% | -$1.56M |
|
4733
PUT
Structure Therapeutics
GPCR
$3.6B
| $2.96M | ﹤0.01% |
67,500
-25,900
| -28% | -$1M |
|
4734
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.3B
| $2.96M | ﹤0.01% |
+43,709
| New | +$2.81M |
|
|
NXDR
4735
Nextdoor Holdings
NXDR
$948M
| $2.96M | ﹤0.01% |
1,193,042
-409,060
| -26% | -$1.05M |
|
4736
CALL
OGE Energy
OGE
$9.69B
| $2.96M | ﹤0.01% |
72,100
-100
| -0.1% | -$3.88K |
|
4737
CALL
Ascendis Pharma A/S
ASND
$17B
| $2.96M | ﹤0.01% |
19,800
-12,800
| -39% | -$1.73M |
|
4738
PUT
NEOS S&P 500 High Income ETF
SPYI
$11.3B
| $2.96M | ﹤0.01% |
57,700
+55,500
| +2,523% | +$2.79M |
|
|
OSG
4739
CALL
Octave Specialty Group
OSG
$205M
| $2.95M | ﹤0.01% |
263,600
+143,300
| +119% | +$1.68M |
|
4740
PUT
Commault Systems
CVLT
$5.69B
| $2.95M | ﹤0.01% |
19,200
+10,100
| +111% | +$1.42M |
|
4741
iShares MSCI Turkey ETF
TUR
$226M
| $2.95M | ﹤0.01% |
+81,183
| New | +$3.19M |
|
4742
CALL
Visteon
VC
$2.81B
| $2.95M | ﹤0.01% |
31,000
+25,900
| +508% | +$2.63M |
|
4743
PUT
Progress Software
PRGS
$1.8B
| $2.95M | ﹤0.01% |
43,800
+7,400
| +20% | +$424K |
|
4744
PUT
Dine Brands
DIN
$428M
| $2.95M | ﹤0.01% |
94,400
+27,200
| +40% | +$876K |
|
4745
PUT
Beazer Homes USA
BZH
$885M
| $2.95M | ﹤0.01% |
86,200
+33,200
| +63% | +$1.02M |
|
|
KEEL
4746
CALL
Keel Infrastructure Corp
KEEL
$2.08B
| $2.94M | ﹤0.01% |
1,395,100
+296,000
| +27% | +$686K |
|
4747
CALL
Sable Offshore Corp
SOC
$973M
| $2.94M | ﹤0.01% |
+124,500
| New | +$2.24M |
|
4748
US Physical Therapy
USPH
$1.18B
| $2.94M | ﹤0.01% |
34,737
-11,745
| -25% | -$1.04M |
|
4749
CALL
National Fuel Gas
NFG
$7.94B
| $2.94M | ﹤0.01% |
48,500
-15,300
| -24% | -$895K |
|
4750
PUT
Insperity
NSP
$1.98B
| $2.94M | ﹤0.01% |
33,400
+12,900
| +63% | +$1.19M |
|
Similar funds
Citadel Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors's Q3 2024 filing shows 1,614 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Citadel Advisors opened 1,614 new positions and closed 1,610 in Q3 2024.
- Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.